Celltrion’s ‘Remsima’ to expand into Middle Eastern market, starting with Saudi Arabia

Celltrion acquired approval to sell Remsima from the Saudi Arabian regulatory authority, the Saudi FDA(Saudi Food and Drug Authority), on the 20^th of April, and begun the sales from the 19^th of Mar.

On a basis of the Saudi Arabian approval, its sales approval procedure in the member countries of the Gulf Corporation Council(GCC), such as Bahrain, Kuwait, Oman, Qatar and the UAE, will be made t...